POONLARP LURSLURCHACHAI: Open Payments
NPI 1205603149 · ROHNERT PARK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,417 in 43 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $717 · 2025 $1,417
Food & beverage: $1,417
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $324 |
| ABBVIE INC. | 11 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $258 |
| Neurocrine BioSciences, Inc. | 3 | $201 |
| Axsome Therapeutics, Inc. | 6 | $167 |
| Lundbeck LLC | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Indivior Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, AUSTEDO XR, Auvelity, UZEDY, REXULTI, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
